CXCR4 chemokine receptor expression in tumor tissue as an additional predictor factor for patients with colon cancer
- Autores: Orlova R.V1,2,3, Ivanova A.K2, Raskin G.A4, Kutukova S.I2,5, Androsova A.V2, Erdniev S.P2, Zhukova N.V1,2, Belyak N.P1,2, Popova N.V2, Avramenko I.V2, Antimonik N.Y.2, Zorina E.Y.2
-
Afiliações:
- St. Petersburg State University
- City Clinical Oncology Dispensary
- Clinical Hospital № 122
- Russian Research Center for Radiology and Surgical Technologies n.a. Acad. A.M. Granov
- Pavlov First St. Petersburg State Medical University
- Edição: Volume 26, Nº 12 (2019)
- Páginas: 44-49
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312339
- DOI: https://doi.org/10.18565/pharmateca.2019.12.44-49
- ID: 312339
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Palavras-chave
Texto integral
Sobre autores
R. Orlova
St. Petersburg State University; City Clinical Oncology Dispensary; Clinical Hospital № 122St. Petersburg, Russia
A. Ivanova
City Clinical Oncology Dispensary
Email: oncolog.ivanova@yandex.ru
Oncologist, Department of Chemotherapy 56, Veteranov Avenue, St. Petersburg 198255, Russian Federation
G. Raskin
Russian Research Center for Radiology and Surgical Technologies n.a. Acad. A.M. GranovSt. Petersburg, Russia
S. Kutukova
City Clinical Oncology Dispensary; Pavlov First St. Petersburg State Medical UniversitySt. Petersburg, Russia
A. Androsova
City Clinical Oncology DispensarySt. Petersburg, Russia
S. Erdniev
City Clinical Oncology DispensarySt. Petersburg, Russia
N. Zhukova
St. Petersburg State University; City Clinical Oncology DispensarySt. Petersburg, Russia
N. Belyak
St. Petersburg State University; City Clinical Oncology DispensarySt. Petersburg, Russia
N. Popova
City Clinical Oncology DispensarySt. Petersburg, Russia
I. Avramenko
City Clinical Oncology DispensarySt. Petersburg, Russia
N. Antimonik
City Clinical Oncology DispensarySt. Petersburg, Russia
E. Zorina
City Clinical Oncology DispensarySt. Petersburg, Russia
Bibliografia
- Каприн А.Д., Старинский В.В., Петрова Г В. Состояние онкологической помощи населению России в 2016 г. М., 2017. 157 с
- Практические рекомендации по лечению злокачественных опухолей Российского общества клинической онкологии, версия. 2017. М., С. 261-64
- Sargent D.J., Marsoni S., Monges G., et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28(30):4664.
- Masahiro Kato, Joji Kitayama, Shinsuke Kazama, Hirokazu Nagawa. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Research. 2003;5(5):R144-R150.
- Чердынцева Н.В., Гервас П.А., Литвяков Н.В. и др. Хемокины и прогрессия злокачественных новообразований. Медицинская иммунология. 2006;8(2-3):355-56
- Симбирцев А.С. Цитокины: классификация и биологические функции. Цитокины и воспаление. 2004;3(2):16-22
- Strieter R.M., Polverini P.J., Kunkel S.L., et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem. 1995;270(45):27348-57. Doi:10.1074/ jbc.270.45.27348.
- Rivera C.G., Bader J.S., Popel A.S. Angiogenesis-associated crosstalk between collagens, CXC chemokines, and thrombospondin domain-containing proteins. Ann Biomed Eng. 2011;39(8):2213-22. doi: 10.1007/s10439-011-0325-2.
- Бережная Н.М., Чехун В.Ф. Иммунология злокачественного роста. Киев, 2005.
- Yu X., Wang D., Wang X., et al. CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p. J Exp Clin Cancer Res. 2019;38(1):32. doi: 10.1186/s13046-018- 1014-x.
- Kim J., Mori T., Chen S.L., et al. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg. 2006;244(1):113-20. doi: 10.1097/01. sla.0000217690.65909.9c